Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Letrozole is one kind of aromatase inhibitors which may have effect on decrease estrogen in luteal phase and inhibit the luteal function of ovary. In 2009, Letrozole was reported as one candidate for the treatment or prevention of ovarian hyperstimulation syndrome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: First Affiliated Hospital, Sun Yat-Sen University
• Treatments: Aspirin; Letrozole

Criteria

Inclusion Criteria:

• infertile women undergoing IVF treatment with more than 25 oocytes collected.

Exclusion Criteria:

• letrozole contraindications,e.g. severe hepatic and renal dysfunction